Multicenter phase II study of oral capecitabine (Xeloda“) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy
Year: 2003
Type: article
Study design: Clinical Trial
Source: Annals of Oncology
Institutions: Humboldt-Universität zu Berlin, Charité – Universitätsmedizin Berlin, University Hospital Frankfurt, University Hospital Schleswig-Holstein, Martin Luther University Halle-Wittenberg, Maastricht University Medical Centre, University Medical Center Freiburg, Technical University of Munich, Essen University Hospital, Heinrich Heine University Düsseldorf, Medizinische Hochschule Hannover
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2143399650
